Results 171 to 180 of about 164,596 (212)
Some of the next articles are maybe not open access.
Metallothioneins and Cisplatin Resistance
1991Intrinsic and acquired resistance to antineoplastic agents has severely limited our ability to cure solid tumors. Cis-diamminedichloroplatinum (cisplatin) represents one of the most efficacious agents for the treatment of solid tumors especially testicular, ovarian, bladder, and head and neck carcinomas.
openaire +1 more source
Overcoming cisplatin resistance in chemotherapy by biomineralization
Chemical Communications, 2013Nano-solidified intermedias (NSI) of cisplatin were prepared via biomineralization and applied to reverse the drug resistance of cancers in vitro and in vivo by an alternative internalization pathway.
Wei, Chen +6 more
openaire +2 more sources
Mechanisms of acquired resistance to cisplatin
1994Since the discovery of the antitumor activity in rodents of cisplatin (cis-diamminedichloroplatinum(II)) in 1968 [1], the use of this drug in treating human disease has grown to the point where it is now one of the most widely used antineoplastics. Cisplatin has an established role in the treatment of testicular, ovarian, bladder, germ cell, and head ...
openaire +2 more sources
Cisplatin resistance: Preclinical findings and clinical implications
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010Cisplatin is used for the treatment of many types of solid cancers. While testicular cancers respond remarkably well to cisplatin, the therapeutic efficacy of cisplatin for other solid cancers is limited because of intrinsic or acquired drug resistance.
Beate, Köberle +3 more
openaire +2 more sources
Cisplatin resistance reversal with treatment of Citric acid in cisplatin-resistant cell lines
ABSTRACTGastric cancer (GC) is a prevalent and aggressive malignancy with significant morbidity and mortality rates, posing a major threat to human health globally. While surgery remains the preferred clinical treatment, chemotherapy continues to be the cornerstone for perioperative care, adjuvant therapy, and palliative treatment for patients with ...Siddhant Chaturvedi, Krishna Venka
openaire +1 more source
Cellular and molecular determinants of cisplatin resistance
European Journal of Cancer, 1998Cisplatin and carboplatin are among the most active and widely used cytotoxic anticancer drugs. However, the acquisition or presence of resistance significantly undermines the curative potential of these drugs against many malignancies. Multiple potential mechanisms of resistance have been identified at the cellular and molecular levels. Alterations in
openaire +2 more sources
Cisplatin resistance and DNA repair
Cancer Treatment Reviews, 1997Crul, M. +3 more
openaire +3 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly